Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2001 | 06-2001 | 03-2001 | 12-2000 | 09-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,257 | -11,488 | -5,338 | -24,960 | -19,150 |
| Depreciation Amortization | 4,601 | 3,057 | 1,334 | 5,950 | 6,620 |
| Accounts receivable | -1,520 | -964 | -708 | 2,211 | N/A |
| Other Working Capital | -14 | -1,279 | -646 | -1,090 | -840 |
| Other Operating Activity | 1,780 | 1,224 | 833 | 1,889 | 990 |
| Operating Cash Flow | $-13,410 | $-9,450 | $-4,525 | $-16,000 | $-12,380 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -24,452 | 7,780 | 4,906 | -7,780 | N/A |
| PPE Investments | -7,672 | -4,285 | -78 | -3,560 | -2,790 |
| Net Acquisitions | N/A | N/A | N/A | -18,560 | 0 |
| Other Investing Activity | 0 | 0 | 0 | 18,560 | -2,820 |
| Investing Cash Flow | $-32,124 | $3,495 | $4,828 | $-11,340 | $-5,610 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 45 | 22,932 | -903 | 572 | N/A |
| Debt Repayment | -114 | -71 | -35 | -473 | N/A |
| Common Stock Issued | 21,667 | 17,652 | 124 | 16,381 | N/A |
| Other Financing Activity | 22,000 | 0 | 0 | 14,900 | 15,910 |
| Financing Cash Flow | $43,598 | $40,513 | $-814 | $31,380 | $15,910 |
| Beginning Cash Position | 11,448 | 11,448 | 11,448 | 7,410 | 7,410 |
| End Cash Position | 9,512 | 46,006 | 10,937 | 11,440 | 5,330 |
| Net Cash Flow | $-1,936 | $34,558 | $-511 | $4,030 | $-2,080 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,410 | -9,450 | -4,525 | -16,000 | -12,380 |
| Capital Expenditure | -7,672 | -4,285 | -78 | -3,563 | N/A |
| Free Cash Flow | -21,082 | -13,735 | -4,603 | -19,563 | -12,380 |